Stay updated with breaking news from 46433010. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) was the target of a significant growth in short interest in October. As of October 31st, there was short interest totalling 9,700,000 shares, a growth of 6.2% from the October 15th total of 9,130,000 shares. Based on an average daily volume of 1,010,000 shares, the short-interest ratio […]
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report)‘s stock had its “outperform” rating reaffirmed by research analysts at William Blair in a research report issued on Monday, RTT News reports. Several other brokerages also recently issued reports on IONS. StockNews.com downgraded Ionis Pharmaceuticals from a “hold” rating to a “sell” rating in a research report on […]
Wrapmanager Inc. lessened its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 7.8% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 7,993 shares of the company’s stock after selling 680 shares during the period. Wrapmanager Inc.’s holdings […]
Victory Capital Management Inc. lowered its stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 2.3% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,088 shares of the company’s stock after selling 351 shares during the quarter. Victory Capital Management Inc.’s […]
Midwest Professional Planners LTD. acquired a new position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 6,593 shares of the company’s stock, valued at approximately $271,000. A number […]